Axon Enterprise, Inc. (AXON) Down 6.0% — Should I Flip This Into Gains?
Axon Enterprise, Inc. (AXON) endured a sharp session on Monday, shedding $36.02 to close at $564.71 on the NASDAQ. The decline was broad and decisive, with sellers maintaining control throughout the day. From a longer-term perspective, the damage is even more pronounced: AXON now sits approximately 28.7% below its 52-week high of $792.16, reached on September 23, 2025—a gap that underscores how much ground the stock has surrendered since its peak and the distance that remains before any meaningful recovery can be declared.
Volume came in at approximately 431,000 shares, running well below the 90-day average of roughly 1.06 million. The lighter turnover during a session that produced a 6% loss is a notable dynamic, suggesting institutional participation was not the primary driver of the selling. Whether that absence of conviction on the downside proves stabilizing in subsequent sessions remains to be seen.
Why Axon Enterprise, Inc. Price is Moving Lower
Monday's selloff in AXON was not a company-specific story but a risk-off macro event that hit expensive growth stocks particularly hard. According to The Wall Street Journal, U.S. forces attacked Iranian rocket launchers in the Strait of Hormuz, triggering a broad flight from higher-multiple names as geopolitical tensions escalated sharply. Brent crude surged above $90 per barrel, stoking fresh concerns about inflation and the Federal Reserve's capacity to ease monetary policy. The VIX jumped 4.92% to 15.14, and the Nasdaq fell roughly 0.44% while the Russell 2000 slid 0.80%—a broad-based retreat that reflected genuine investor anxiety rather than isolated stock-specific news. Oil itself rose 2.21% to $85.24 on the session.
Axon was among the hardest hit because of the particular vulnerability that comes with carrying a forward P/E of 249. When bond yields and geopolitical risk rise simultaneously, investors grow less willing to pay a steep premium for profits that won't materialize for years—and AXON's valuation profile makes it a natural target for that rotation. The stock's 6.0% decline well outpaced the broader index drawdown, illustrating how sharply high-multiple names can reprice when the macro backdrop deteriorates. This is not a new dynamic for Axon; the stock has been susceptible to rate-sensitivity narratives throughout the past twelve months, and Monday's session reinforced that pattern.
It is worth acknowledging that the most recent quarterly results—reported on August 5—were not the problem. Axon delivered an adjusted EPS of $1.88 against the $1.84 consensus estimate and revenue of $904.39 million against expectations of $876.42 million, a beat on both lines. Revenue grew 35.3% year over year from $668.54 million, a genuinely impressive top-line acceleration. However, adjusted EPS declined 11.3% from $2.12 a year ago, and net income fell 18.5% to $29.4 million—a combination that signals expanding costs are eating into the bottom line even as sales surge. That earnings quality gap was already a known overhang before Monday; the geopolitical shock simply added another layer of pressure to a stock that was already navigating a complicated fundamental picture.
What is the Axon Enterprise, Inc. Rating - Should I Sell?
Weiss Ratings assigns AXON a C- rating. Current recommendation is Hold.
The C- reflects a profile where genuine operating strengths coexist with meaningful vulnerabilities that investors cannot afford to overlook. Revenue growth of 35.28% is the clearest positive in the model, a top-line expansion rate that few companies at Axon's scale can match and one that earns a Fair Growth Index—a label that acknowledges the momentum while noting it hasn't yet translated consistently into bottom-line power. The Good Efficiency Index, supported by an ROE of 6.22%, is a modest positive for a capital goods business, though that return level is far from exceptional for a company demanding the valuation premium AXON carries. The Excellent Solvency Index is perhaps the most unambiguous bright spot, indicating that the balance sheet is not a near-term risk even as the company absorbs higher costs.
Where the rating is pulled lower is on risk and return delivery. The Weak Volatility Index is a direct warning: AXON has exhibited price swings that many investors will find difficult to stomach, and Monday's 6% single-session decline is a live example of what that index is flagging. A forward P/E of 249 leaves the stock exceptionally exposed to any macro environment that compresses multiples—rising yields, geopolitical shocks, or a simple recalibration of growth expectations can each trigger outsized moves. The Fair Total Return Index suggests that the stock's historical returns, adjusted for its risk profile, have not justified the premium on a consistent basis. A 6.19% profit margin underscores the tension at the core of the thesis: revenue is growing rapidly, but converting that scale into durable earnings remains an unfinished project.
Within the Industrials sector, AXON ranks below its peer group. Deere & Company (DE, C+), Vertiv Holdings Co (VRT, C+), Quanta Services, Inc. (PWR, C+), Emerson Electric Co. (EMR, C+), and Northrop Grumman Corporation (NOC, C+) all carry C+ ratings—a full notch above Axon on the Weiss scale. That relative positioning is meaningful: those businesses generally offer more balanced combinations of profitability, valuation discipline, and volatility management. For investors weighing options across the Industrials landscape, the peer comparison argues for caution on AXON at current levels rather than aggressive accumulation.
About Axon Enterprise, Inc.
Axon Enterprise, Inc. (AXON) is an Industrials company and the dominant supplier of conducted energy devices—most recognizably the TASER—alongside a rapidly expanding ecosystem of software, cameras, and cloud-based data management tools designed for law enforcement, corrections, and public safety agencies. The company's hardware portfolio includes body-worn cameras, in-car video systems, and drone technology, all of which feed into its Axon Evidence cloud platform, a centralized repository that allows agencies to store, manage, and share digital evidence securely. That software layer is increasingly the strategic heart of the business, as recurring subscription revenue carries higher margins and longer contract durations than device sales alone.
Axon's go-to-market model is built around deep integration with public safety workflows—once an agency deploys the full technology stack, switching costs are substantial, creating durable customer relationships that support multi-year contract renewals. The company has also made deliberate moves into international markets, where law enforcement modernization is earlier in cycle than in the United States, representing a meaningful long-runway growth opportunity. Recent product development has focused on artificial intelligence applications layered atop its existing data platforms, including automated report writing and real-time analytics tools that aim to reduce administrative burden for officers in the field.
Beyond law enforcement, Axon has been exploring adjacencies in federal, military, and private security markets, broadening the potential addressable base for its hardware and software offerings. The company's intellectual property position in non-lethal force technology remains substantial, built over decades of product iteration and regulatory engagement. Competitive advantages include its installed base scale, proprietary evidence management infrastructure, and the regulatory and procurement relationships that come with being the category-defining supplier in its core market—barriers that new entrants would find difficult and time-consuming to replicate.
Investor Outlook
Axon Enterprise, Inc. (AXON) carries a Weiss Rating of C- (Hold), and the events of August 31 serve as a clear illustration of the risks embedded in that rating—particularly the Weak Volatility Index and the valuation exposure that comes with a forward P/E of 249. In the near term, investors should watch for any escalation or de-escalation in Middle East tensions, shifts in bond yields, and whether Axon's next earnings cycle demonstrates meaningful progress in converting strong revenue growth into durable bottom-line improvement. See full rankings of all C--rated Industrials stocks inside the Weiss Stock Screener.
--